| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Manuel Ramos-casals | Q42646201 |
| P2093 | author name string | Brito-Zerón P | |
| P2860 | cites work | RETRACTED: Infliximab in primary Sjögren's syndrome: one-year followup | Q56765401 |
| RETRACTED: Infliximab in patients with primary Sjögren's syndrome: a pilot study | Q56765531 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1389-1396 | |
| P577 | publication date | 2007-06-22 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Emerging biological therapies in primary Sjogren's syndrome | |
| P478 | volume | 46 |
| Q26772937 | Aquaporins in Salivary Glands: From Basic Research to Clinical Applications |
| Q92150187 | Inclusion body myositis: clinical features and pathogenesis |
| Q46573171 | Is mizoribine a new therapeutic agent for Sjögren's syndrome? |
| Q37117336 | Oral manifestations of Sjögren's syndrome |
| Q38076460 | Primary Sjögren syndrome: an update on current pharmacotherapy options and future directions. |
| Q37330297 | Renal involvement in primary Sjögren's syndrome: a clinicopathologic study |
| Q26777907 | Salivary Secretory Disorders, Inducing Drugs, and Clinical Management |
| Q64938813 | Sjögren's and plasma cell variant Castleman disease: a case report |
| Q38198637 | Tracking and treating activated T cells. |
| Q38795404 | Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects |
| Q50624594 | Usefulness of MR imaging of the parotid glands in patients with secondary Sjögren's syndrome associated with rheumatoid arthritis. |
| Q84600763 | [New therapeutic targets] |
| Q84600753 | [Sjögren's Syndrome] |
Search more.